inactivate < inactivated < inactivating

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 65.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000017 (1973)	Steven R. Mostow ; Stephen C. Schoenbaum ; Walter R. Dowdle ; Marion T. Coleman ; Harold S. Kaye	Inactivated vaccines. 1. Volunteer studies with very high doses of influenza vaccine purified by zonal ultracentrifugation
000081 (1973)	William M. Marine ; James E. Thomas	Age-related response to 1000 CCA unit zonally purified, inactivated influenza vaccines in volunteers in the U.S.A
000092 (2000)	N. V. Kaverin ; Y. A. Smirnov ; E. A. Govorkova ; I. A. Rudneva ; A. K. Gitelman ; A. S. Lipatov ; N. L. Varich ; S. S. Yamnikova ; N. V. Makarova ; R. G. Webster [États-Unis] ; D. K. Lvov	Cross-protection and reassortment studies with avian H2 influenza viruses
000112 (2001)	L. G Rudenko [Russie] ; G. I Alexandrova [Russie]	Current strategies for the prevention of influenza by the Russian cold-adapted live influenza vaccine among different populations
000128 (1981)	D. Armerding [Autriche] ; E. Liehl [Autriche]	Induction of homotypic and heterotypic T- and B-cell immunity with influenza A virus in mice
000155 (2001)	M. D Wareing [Australie] ; G. A Tannock [Australie]	Live attenuated vaccines against influenza; an historical review
000156 (1977)	Anton Mayr [Allemagne] ; Barbara Bibrack [Allemagne]	Untersuchungen über die Wirksamkeit einer Kombinationsvaccine gegen virusbedingte, respiratorische Erkrankungen des Hundes („Zwingerhustenrdquor;, kennel cough, infektiöse Tracheobronchitis)
000365 (1999)	M. Pfleiderer ; J. Löwer ; R. Kurth	Influenza-Lebendimpfstoffe – eine Nutzen-Risiko-Bewertung
000402 (1988)	R. G. Webster [États-Unis] ; P. A. Reay [Royaume-Uni] ; W. G. Laver [Australie]	Protection against lethal influenza with neuraminidase
000409 (1990)	Peter S. Holt [Grèce]	Enhancement of chicken lymphocyte activation and lymphokine release by avian influenza virus
000435 (1984)	K. Noel Masihi [Allemagne] ; Werner Lange [Allemagne] ; Sybille Müller [Allemagne]	Depression of chemiluminescence response in mouse spleen cells by infective and inactivated influenza virus
000530 (1990)	L. A. White [États-Unis] ; C. Y. Freeman [États-Unis] ; H. E. Hall [États-Unis] ; B. D. Forrester [États-Unis]	Inactivation and stability of viral diagnostic reagents treated by gamma radiation
000531 (1990)	Paul A. Rota [États-Unis] ; Barun K. De [États-Unis] ; Michael W. Shaw [États-Unis] ; Renee A. Black [États-Unis] ; William C. Gamble [États-Unis] ; Alan P. Kendal [États-Unis]	Comparison of inactivated, live and recombinant DNA vaccines against influenza virus in a mouse model
000533 (1984)	Marylou Clements [États-Unis] ; Robertf Betts [États-Unis] ; Brianr Murphy [États-Unis]	ADVANTAGE OF LIVE ATTENUATED COLD-ADAPTED INFLUENZA A VIRUS OVER INACTIVATED VACCINE FOR A/WASHINGTON/80 (H3N2) WILD-TYPE VIRUS INFECTION
000581 (1981)	H. Ertl [Australie] ; G. L. Ada [Australie]	Roles of influenza virus infectivity and glycosylation of viral antigen for recognition of target cells by cytolytic T Lymphocytes
000592 (1976)	F. A. Ennis ; M. A. Wells ; D. W. Barry ; S. Daniel ; J. Manischewitz	Host defence mechanisms against influenza infection. II. Protection of mice with vaccines against A/Port Chalmers/1/73 and B/Hong Kong/5/72
000627 (1982)	Y. Debets-Ossenkopp [Pays-Bas] ; E. L. Mills [Pays-Bas] ; W. C. Van Dijk [Pays-Bas] ; H. A. Verbrugh [Pays-Bas] ; J. Verhoef [Pays-Bas]	Effect of influenza viras on phagocytic cells
000642 (2001)	Yuri A. Smirnov [Russie] ; Nikolai V. Kaverin [Russie] ; Elena A. Govorkova [Russie] ; Alexander S. Lipatov [Russie] ; Eric C. J. Claas [Pays-Bas] ; Natalia V. Makarova [Russie] ; Asya K. Gitelman [Russie] ; Robert G. Webster [États-Unis] ; Dmitri K. Lvov [Russie]	Cross-protection studies with H5 influenza viruses
000679 (2001)	Kimberly A. Benton [États-Unis] ; Julia A. Misplon [États-Unis] ; Chia-Yun Lo [États-Unis] ; Suzanne L. Epstein [États-Unis]	Susceptibility and immunity to influenza A strains in Ig−/−mice
000695 (2006)	S. Smith [Royaume-Uni] ; V. Demicheli ; C. Di Pietrantonj ; Ar Harnden ; T. Jefferson ; Nj Matheson ; A. Rivetti	Vaccines for preventing influenza in healthy children
000702 (1973)	W. R. Dowdle ; M. T. Coleman ; S. R. Mostow ; H. S. Kaye ; S. C. Schoenbaum	Inactivated vaccines. 2. Laboratory indices of protection

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "inactivated" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "inactivated" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    inactivated
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021